Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
14
pubmed:dateCreated
2005-12-1
pubmed:abstractText
The Src homology domain 2 (SH2)-containing tyrosine phosphatase-1 (SHP-1) plays a key role in apoptosis and decreases phosphorylation of Akt. Apoptosis of cardiomyocytes is thought to contribute to the increased area of acute myocardial infarction (AMI), and Akt activation exerts a powerful cardioprotective effect after ischemia. Thus, a therapeutic strategy designed to inhibit expression of SHP-1 would be beneficial in AMI. Here we report that siRNA targeting SHP-1 reduced infarct size in a rat model of AMI. Upon injection into the ischemic left ventricular wall, the vector-based siRNA significantly suppressed the increase in the SHP-1 mRNA and the SHP-1 protein levels. The siRNA vector also significantly reduced the SHP-1 that bound to Fas-R. The SHP-1 siRNA vector increased phospho-Akt and reduced DNA fragmentation and caspase activity compared with the scramble siRNA vector. Finally, the area of myocardial infarction was significantly smaller with the SHP-1 siRNA vector than with the scramble siRNA vector at 2 days after LCA ligation. In conclusion, SHP-1 in the heart increased from the early stage of AMI, and this increase was thought to contribute to the increased area of myocardial infarction. Suppression of SHP-1 with the SHP-1 siRNA vector markedly reduced the infarct size in AMI.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
1530-6860
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
19
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2054-6
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:16223786-Animals, pubmed-meshheading:16223786-Antigens, CD95, pubmed-meshheading:16223786-Apoptosis, pubmed-meshheading:16223786-Blotting, Northern, pubmed-meshheading:16223786-Blotting, Western, pubmed-meshheading:16223786-Caspases, pubmed-meshheading:16223786-Coronary Vessels, pubmed-meshheading:16223786-DNA Fragmentation, pubmed-meshheading:16223786-Echocardiography, pubmed-meshheading:16223786-Gene Therapy, pubmed-meshheading:16223786-Genetic Vectors, pubmed-meshheading:16223786-Heart Ventricles, pubmed-meshheading:16223786-Immunoprecipitation, pubmed-meshheading:16223786-Intracellular Signaling Peptides and Proteins, pubmed-meshheading:16223786-Male, pubmed-meshheading:16223786-Models, Biological, pubmed-meshheading:16223786-Myocardial Infarction, pubmed-meshheading:16223786-Myocardial Ischemia, pubmed-meshheading:16223786-Myocardium, pubmed-meshheading:16223786-Myocytes, Cardiac, pubmed-meshheading:16223786-Protein Phosphatase 1, pubmed-meshheading:16223786-Protein Tyrosine Phosphatase, Non-Receptor Type 6, pubmed-meshheading:16223786-Protein Tyrosine Phosphatases, pubmed-meshheading:16223786-RNA, Messenger, pubmed-meshheading:16223786-RNA, Small Interfering, pubmed-meshheading:16223786-RNA Interference, pubmed-meshheading:16223786-Rats, pubmed-meshheading:16223786-Rats, Wistar, pubmed-meshheading:16223786-Time Factors, pubmed-meshheading:16223786-src Homology Domains
pubmed:year
2005
pubmed:articleTitle
RNA interference targeting SHP-1 attenuates myocardial infarction in rats.
pubmed:affiliation
Department of Molecular and Cellular Biology, Division of Molecular and Clinical Gerontology, Medical Institute of Bioregulation, Kyushu University, Beppu, Oita, Japan.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't